Paramount Promises 30 Films per Year to Win Merger Approval

Paramount’s acquisition of Warner Bros. Discovery cleared a major regulatory hurdle this week after the combined studio agreed to theatrical release commitments that satisfied state antitrust concerns. The settlement stipulates that the newly merged company will release at least 30 films into theaters annually for 2027 and 2028, increasing to at least 32 films per year for 2029, 2030, and 2031. CEO David Ellison has framed this as roughly one new movie every 11 days, a pledge aimed at addressing Hollywood’s ongoing shortage of theatrical content since the pandemic disrupted production and theater operations.

The agreement has won backing from major cinema chains and their lobbying groups, yet skepticism persists among smaller theater operators and industry analysts about whether the merged company can sustain such output after the five-year deal expires. The settlement includes specific guardrails: at least 20 films per year in the first two years must receive wide releases to more than 2,000 theaters, increasing to at least 21 films in years three through five. Additionally, at least 20 percent of annual releases must be tentpole films with budgets exceeding $50 million. Paramount faces $30 million in fines per unmet film, with 90 percent directed to film workers and 10 percent to state attorneys general.

Exhibit A: Why The Industry Welcomed The Deal

Cinema United, the theater owners’ lobbying organization, had opposed the merger but reversed course after the settlement, saying the agreement “accomplishes many of exhibition’s objectives.” The leaders of the three largest cinema chains, AMC’s Adam Aron, Cinemark’s Sean Gamble, and Regal’s Eduardo Acuna, endorsed Ellison’s theatrical commitment even before the formal settlement was announced at CinemaCon in April.

The backing reflects genuine need. Hollywood has starved theaters of content since 2020. Higher ticket prices have masked some revenue losses and are expected to push the domestic box office above $10 billion for the first time since the pandemic, but the underlying problem remains: fewer films and fewer moviegoers have fundamentally reshaped theater economics.

The Skeptics’ Case: Consolidation And Calendar Conflicts

Several theater executives who requested anonymity told CNBC they remain skeptical of the merged company’s ability to maintain output levels. Their concerns center on three problems: consolidation reduces the number of studios contributing films, limits competition on windowing and rental fees, and gives the combined company stronger bargaining leverage against smaller theater chains with less negotiating power.

A second practical issue is scheduling. With 52 weeks on the calendar, 30 films means fewer than two weeks between releases, not accounting for major premiere weekends when studios typically stack blockbusters. The merged slate already shows six dates in 2027 where both legacy studios have theatrical releases scheduled, and multiple weeks with three to five releases stacked together.

Cannibalization is the resulting risk. One box office analyst told CNBC that the company will likely need to shift release dates to avoid overlapping audiences and diversify cadence. The combined 2027 slate includes nine horror films alone, suggesting that aggressive counterprogramming across genres will be essential to prevent internal competition.

Definitions Matter More Than The Numbers Suggest

Industry analyst David Poland flagged a structural weakness: the agreement requires only 20 wide releases annually, which he called “nothing.” That threshold is significantly lower than the combined studios’ current trajectory. Paramount is on track for 14 wide releases in 2026, while Warner Bros. has scheduled 13, totaling 27 wide releases between them. The agreement effectively mandates fewer wide releases than the two studios would likely produce independently.

The tentpole definition presents another caveat. Hollywood traditionally defines a tentpole as a film with a budget exceeding $100 million, often $200 to $250 million, that generates enough revenue to fund smaller projects. The Paramount settlement defines tentpole as just $50 million in production budget, a threshold industry observers describe as relatively modest for what blockbuster franchises typically cost to produce and market.

Paul Dergarabedian, head of marketplace trends at Rentrak, noted that quality and performance ultimately matter more than volume. “Thirty wide releases would represent a meaningful commitment to theatrical,” he said, but “the proof will be in how those movies perform, how varied the slate is, how consistently they reach theaters and how the combined company executes on those commitments.”

What Happens After Year Five

Rob Lehman, president and chief operating officer at Santikos Theaters, captured the lingering anxiety in a single question: “Of course, I worry about what happens in year six. After the five years is up, does it then drop down to 18 movies a year?”

The merged company will carry approximately $79 billion in debt once the merger closes, raising legitimate questions about its ability to sustain 30-plus theatrical releases indefinitely as production and marketing costs continue rising. The $30 million-per-film penalty provides some enforcement, but it pales against production budgets and is unlikely to prevent a pullback once the settlement expires.

For now, the combined company has secured regulatory approval and major chain backing. The real test begins in 2027, when audiences will discover whether a studio producing three films per week can deliver hits that warrant theatrical play, or whether volume alone becomes the story.